"Although psychedelics have potential in mental health care, FDA approval of new drugs should always be based on rigorous evidence of safety and efficacy." "By rejecting the approval of MDMA, the FDA will encourage this company and other researchers of psychedelic drugs to conduct more rigorous ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is a clinical-stage psychedelics biotech company focused on the research, development and commercialization of novel uses, formulations and delivery methods of psychedelics to treat mental illness, neurological and pain disorders. Phar...